Location History:
- North Garden, VA (US) (1996 - 2006)
- Charlottesville, VA (US) (1988 - 2022)
Company Filing History:
7 out of 998 
4 out of 3,580 
3 out of 9 Years Active: 1988-2022
Title: Michael Oliver Thorner: Innovator in Growth Hormone Research
Introduction
Michael Oliver Thorner is a prominent inventor based in Charlottesville, VA (US). He has made significant contributions to the field of medicine, particularly in the area of growth hormone deficiency. With a total of 14 patents to his name, Thorner's work has had a substantial impact on the understanding and treatment of this condition.
Latest Patents
Among his latest patents is a groundbreaking method for detecting and treating growth hormone deficiency (GHD). This innovative approach utilizes MK-0677, a new oral method that aids in the detection of GHD. Additionally, it describes a method for treating GHD in children who possess a functional hypothalamic-pituitary GH axis. This dual focus on detection and treatment showcases Thorner's commitment to advancing medical science.
Career Highlights
Thorner has had a distinguished career, working with notable institutions such as the University of Virginia and American Cyanamid Company. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Some of Thorner's notable coworkers include Bruce D. Gaylinn and John R. Zysk. Their collaborative efforts have contributed to the success of his research and the development of his patents.
Conclusion
Michael Oliver Thorner's innovative work in the field of growth hormone research has led to significant advancements in the detection and treatment of growth hormone deficiency. His contributions continue to influence the medical community and improve patient outcomes.